dipyridamole has been researched along with MELAS in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In four patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) in which mutated mitochondrial deoxyribonucleic acid was seen, hypertrophic cardiomyopathy and angiopathy was demonstrated by echocardiography, dipyridamole stress scintigraphy, and cardiac catheterization." | 3.69 | Cardiomyopathy and angiopathy in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. ( Goto, A; Harada, K; Kobayashi, Y; Miura, Y; Nemoto, T; Ozawa, T; Sato, W; Sugiyama, S; Takada, G; Tanaka, M, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, W | 1 |
| Tanaka, M | 1 |
| Sugiyama, S | 1 |
| Nemoto, T | 1 |
| Harada, K | 1 |
| Miura, Y | 1 |
| Kobayashi, Y | 1 |
| Goto, A | 1 |
| Takada, G | 1 |
| Ozawa, T | 1 |
1 other study available for dipyridamole and MELAS
| Article | Year |
|---|---|
Cardiomyopathy and angiopathy in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes.
Topics: Adolescent; Adult; Biochemical Phenomena; Biochemistry; Biopsy; Blotting, Western; Cardiac Catheteri | 1994 |